Ra Pharmaceuticals' Series A - II Round

Ra Pharmaceuticals raised a round of funding on May 16, 2012.

Ra Pharma combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorders. The company's proprietary peptide ch…

Articles about Ra Pharmaceuticals' Series A - II Round: